Announced
Synopsis
Naxicap Partners-backed Ceres Pharma, a Belgian based dynamic and fast growing pharmaceutical company, agreed to acquire Dacia Plant, a firm active in the development, production and distribution of qualitative and innovative natural food supplements and vitamins. Financial terms were not disclosed. "I am very happy that we have come to an agreement with Dacia Plant. This acquisition fits perfectly within Ceres Pharma’s women and family health strategy. The demand for natural products is growing everywhere. With Dacia Plant we will reinforce our position in Romania and we can strengthen our product portfolio outside Romania with a broad range of Natural Phytotherapy Products," Mario Debel, Ceres Pharma CEO.
Principals
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
Seller Team (5)
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
All rights reserved. Copyright © 2025 Datasite